About Biaffin
Biaffin is a Healthcare company based in Kassel (Germany) founded in 1999. It offers SPR technology for analyzing protein interactions and drug development services. It operates on a B2B model. Biaffin offers products and services including Biacore SPR Services, Recombinant Kinases, and Kinase Inhibitors. Its focus areas include Biotech, Drug Development, Therapeutic Analysis and Bioanalytical Services. Its legal entity is Biaffin GmbH & Co. KG. Its competitors include BioAgilytix, Alderley Analytical, Tentamus, Nordic Bioscience and Solvias and 5 more; 3 of its 10 listed competitors have raised funding.
Company details
Biaffin GmbH Co. KG, located in Kassel, Germany, specializes in Surface Plasmon Resonance (SPR) technology using Biacore instruments to analyze biomolecular interactions in real-time. They deliver high-quality bioanalytical services, including kinetic measurements and antibody characterization, for clients in the pharmaceutical, diagnostic industries, and academia. Their expertise supports drug development, lead optimization, and protein analysis through tailored assay plans and state-of-the-art equipment.
- Headquarters Kassel, Germany
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website biaffin.com
- Social Facebook
- Legal Name Biaffin Gmbh & Co. Kg
Products & Services of Biaffin
Biaffin offers a comprehensive portfolio of products and services, including Biacore SPR Services, Recombinant Kinases, and Kinase Inhibitors.
Real-time analysis of biomolecular interactions using SPR technology.
Proteins for research in kinase interactions and drug screening.
Compounds for inhibiting protein kinases in therapeutic applications.
Competitors of Biaffin
Biaffin has 10 listed competitors in our database, 3 of them funded. They include BioAgilytix, Alderley Analytical, Tentamus, Nordic Bioscience and Solvias, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| bioagilytix.com | 2008 | Durham, United States | – | 446 | Large-molecule bioanalysis is provided for biologics and biosimilars development. | |
| alderleyanalytical.com | 2013 | Stockport, United Kingdom | $869,352 | 41 | Bioanalytical assays for drug development are developed and validated. | |
| tentamus.com | 2011 | Berlin, Germany | – | 368 | Analytical and quality assurance services are provided for diverse industries. | |
| nordicbioscience.com | 1996 | Herlev, Denmark | – | 178 | Preclinical and clinical drug development CRO with proprietary in-house Biomarker platform | |
| solvias.com | 1999 | Kaiseraugst, Switzerland | – | – | Integrated R&D services are provided for pharmaceuticals and allied sectors. | |
| advion.com | 1993 | Ithaca, United States | $45.64M | 54 | Microfluidics and mass spectrometry products are provided for clinical research. | |
| synexagroup.com | 2003 | Cape Town, South Africa | – | – | Provider of comprehensive analytical and advisory services, specializing in biomarker services | |
| eag.com | 1978 | San Diego, United States | – | 601 | Company offering a suite of scientific services for materials, engineering, agri, and life science industries | |
| lightcast.bio | 2019 | Cambridge, United Kingdom | $107.09M | 25 | Advanced single-cell analysis solutions are provided for biotechnology research. | |
| apocell.com | 2004 | Houston, United States | – | 2,198 | Provider of clinical trial and clinical development on bioanalytical services |
Detailed competitors of Biaffin
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Biaffin
Websites that share an audience with Biaffin (biaffin.com).
Websites whose visitors overlap most with Biaffin. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| bioatla.com | 100% | 15.1K | #1,740,050 | View details | |
| dalton.com | 92% | 4.8K | #3,789,431 | View details |
Top companies in Immunology & Cancer Therapeutics
10 companies that operate in the same segment as Biaffin (Immunology & Cancer Therapeutics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment. | 2008 | Ghent, East Flanders, Belgium | USD 61.9 M | USD 1.41 B | 355 | |
Targeted and immune-oncology drugs for cancer treatment are developed. | 2010 | Cambridge, Massachusetts, United States | USD 172 M | – | – | |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Targeted therapies for cancer treatment are developed. | 2005 | Waltham, Massachusetts, United States | USD 198.29 M | USD 172.35 M | 270 | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Plasma-based biologics are developed for immune deficiency and infectious diseases. | 2005 | Ramsey, Minnesota, United States | USD 17.55 M | USD 510.17 M | 685 | |
Antibody drugs for cancer treatment are developed. | 2015 | Singapore, Singapore | USD 150 M | – | – | |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | – | 520 | |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | 2003 | United States | USD 171.85 M | USD 102.48 M | 338 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Biaffin
Biaffin was founded in 1999.
Biaffin is headquartered in Kassel, Germany. It is registered at Kassel, Hesse, Germany.
Biaffin GmbH Co. KG, located in Kassel, Germany, specializes in Surface Plasmon Resonance (SPR) technology using Biacore instruments to analyze biomolecular interactions in real-time. They deliver high-quality bioanalytical services, including kinetic measurements and antibody characterization, for clients in the pharmaceutical, diagnostic industries, and academia. Their expertise supports drug development, lead optimization, and protein analysis through tailored assay plans and state-of-the-art equipment.
Biaffin's top competitors include Alderley Analytical, BioAgilytix and Lightcast Discovery.
Biaffin offers Biacore SPR Services, Recombinant Kinases, and Kinase Inhibitors.
Biaffin operates through Biaffin Gmbh & Co. Kg.